|
|
||||||||
Radiologic-Pathologic Conferences of |
1
Division of Diagnostic Imaging, The University of Texas M. D. Anderson Cancer
Center, Box 57, 1515 Holcombe Blvd., Houston, TX 77030.
2
Division of Pathology, The University of Texas M. D. Anderson Cancer Center,
Houston, TX 77030.
Received March 15, 2001;
accepted after revision April 2, 2001.
Address correspondence to R. B. Iyer.
Introduction
|
|
|---|
|
|
|
|
Uterine lipoleiomyoma is a rare benign tumor. The reported incidence varies from 0.03% to 0.2% [1]. Lipoleiomyomas of the uterus are typically found in postmenopausal women and are associated with ordinary leiomyomas. The signs and symptoms are similar to those caused by leiomyomas of the same size, such as a palpable mass, hypermenorrhea, and pelvic pain. Most patients are asymptomatic [2]. Uterine lipoleiomyomas are most frequently found in the uterine corpus and are usually intramural. Lipoleiomyomas can be found anywhere in the uterus or cervix and may be subserosal [3].
Lipoleiomyomas are composed histologically of variable amounts of smooth muscle, fat cells, and fibrous tissue. Fatty metamorphosis of smooth muscle cells of leiomyomas is the most likely cause for the development of lipoleiomyomas [4].
The sonographic appearance of leiomyomas is that of a hyperechoic mass partially encased by a hypoechoic rind. The rind is thought to represent a layer of myometrium surrounding the fatty component [1, 5]. CT shows more specific findings, revealing a well-circumscribed, predominantly fatty mass with areas of nonfat soft-tissue density arising from the uterus [1,2,3,4,5]. On MR imaging, the lipomatous nature of the lesion is suggested by high signal intensity on T1-weighted images and chemical shift artifacts in the lesion. The fatty components may be confirmed using fat-suppression techniques [3, 5, 6].
Imaging plays an important role in determining the intrauterine location and fatty nature of lipoleiomyomas. Imaging is used to differentiate uterine lipoleiomyomas from cystic ovarian teratomas because teratomas are usually surgically excised, whereas lipoleiomyomas require no therapy [5].
|
|
|---|
This article has been cited by other articles:
![]() |
A N Keeling and J F Reidy Imaging and treatment of uterine fibroids, including the role of uterine artery embolization Imaging, December 1, 2007; 19(4): 374 - 384. [Abstract] [Full Text] [PDF] |
||||
![]() |
J L Hughes and J F Reidy Imaging and treatment of uterine fibroids including the role of uterine artery embolisation Imaging, June 1, 2003; 15(2): 79 - 88. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |